Studieoverzicht
|
BOOG nr.: |
Status: ( Follow up )
|
Indication: ( View all )
|
Subindication: |
Menopausal status: |
| 2017-04 BYLieve | Follow up | Advanced/metastatic | HER2- HR+ | Not applicable | ||||||||||||||
| 2016-03 PRECISE | Follow up | Adjuvant | Not applicable | Not applicable | ||||||||||||||
| 2014-05 INFLAME | Follow up | Data registration | Not applicable | Not applicable | ||||||||||||||
| 2013-02 Male BC prospectief | Follow up | Data registration | Not applicable | Not applicable | ||||||||||||||
| 2009-03 DCIS | Follow up | Locoregional | Not applicable | Not applicable | ||||||||||||||
| 2009-01 IRMA | Follow up | Locoregional | Not applicable | Not applicable | ||||||||||||||
| 2006-03 SUPREMO | Follow up | Locoregional | Not applicable | Not applicable | ||||||||||||||
| 2004-01 Young Boost | Follow up | Locoregional | Not applicable | Not applicable |